Factors Affecting Treatment Compliance In Tb Patients (Tuberculosis) During Pandemic Covid-19 At Labuang Baji Makassar Hospital

Authors

  • Imelda Appulembang Lecturer OfBechalor Health Nursing, STIKES Gunung Sari, Indonesia
  • Ana Lita Luto Wujon Health Nursing, STIKES Gunung Sari, Indonesia
  • Dana Briggs California State University, Monterey Baydisabled, Marina, United States
  • Maher Nasser Abdullah Al-Muthanna University, Iraq

DOI:

https://doi.org/10.51601/ijhp.v1i1.3

Keywords:

Knowledge, anxiety family support, medication adherence

Abstract

Tuberculosis (TB) is an infectious disease caused by the bacteria Mycobacterium tuberculosis (World Health Organization. Tuberculosis (TB) is also one of the main public health problems that has become one of the biggest threats in the world, in addition to the COVID-19 pandemic. Currently, TB (tuberculosis) is one of the risk factors for a person to be susceptible to being infected with COVID-19. The aim of the study was to determine the factors that influence medication adherence in TB (tuberculosis) patients during the Covid-19 pandemic at the LabuangBaji Hospital, Makassar. The research design used in this study is descriptive analytic research using a cross sectional study design. To determine the relationship between the independent variable and the dependent variable using joint measurements, the population is 128 people. respondents, the measuring instrument for measuring data is using a questionnaire. There is an influence between the knowledge variable about TB disease (tuberculosis) on the adherence to treatment of TB patients (tuberculosis) during the covid-19 pandemic at LabuangBaji Hospital Makassar showing a value (0.005 < 0.05), There is an influence between the variables of family support on treatment adherence TB patients (tuberculosis) during the covid-19 pandemic at LabuangBaji Hospital Makassar showed a value (0.003 < 0.05), There was an influence between the anxiety variable on adherence to treatment for TB patients (tuberculosis) during the covid-19 pandemic, LabuangBaji Hospital Makassar showed a value (0.001 < 0.05). There is an influence between knowledge of TB disease (tuberculosis), family support, anxiety and adherence to treatment for TB patients during the covid-19 pandemic at LabuangBaji Hospital Makassar.

References

Anita Yeni, Erlisa Candrawati, Ragil Catur A.W. 2015 Pengetahuan Pasien Tubercullosis Brimplikasih Terhadap

Kepatuhan Berobat. Universitas Tribhuwana Tungga dewi Malang.

ArniWianti .2017,Hubungan Dukungan Keluarga Dengan Kepatuhan Minum Obat Pada Pasien Tuberculosis

Paru. Di Puskesmas Kaladawa Kabupaten Tegal.

International Journal of Health and Pharmaceutical

https://ijhp.net

Eli Kurniasih, Vina Jovita Nurfajriani 2021. Gambaran Tingkat Kecemasan Pasien TB Paru Telaah Literatur.

STIKes Bakti Tunas Husada Tasikmlaya.

Kemenkes RI,2017. Data dan Informasi Kesehatan Profil Kesehatan Indonesia 2016

Kementerian Kesehatan RI. (2020). Pedoman Pencegahan dan Pengendalian. Coronavirus Diseases (covid-19).

Jakarta Selatan: KementerianKesehatan RI.

Kementerian Kesehatan Republik Indonesia 2020, Pedoman Pencegahan dan Pengendalian COVID-19, accesed

mei 2020, available from

UNIVERSITAS SUMATERAUTARA http://ww.kemkes.go.id/resorces/dowload/info-terkini/

COVID-19%20corona virus%20Disease%20(COVID-19).pdf

Infodatin TBC Indonesia. (2018). Tuberkolosis. Pusat Data danInformasiKementerianKesehatan

Shen Et al. (2014). Pengaruh cognitive dan Acceptance and Commitment Therapy terhadap Ansietas, Depresi

Klien Tuberkulosis. Jurnal Ilmiah Keperawatan. Vol 9. No 1 Surabaya

WHO. (2020). Corona virus disease 2019 (COVID-19). URL http://www.euro.who.int/en/health-topics/healthmergencies/coronavirus-covid-19/technical-guidance/mental-health-and-covid-1

Downloads

Published

2021-11-07

How to Cite

Appulembang, I. ., Lita Luto Wujon, A. ., Briggs , D. ., & Nasser Abdullah, M. . (2021). Factors Affecting Treatment Compliance In Tb Patients (Tuberculosis) During Pandemic Covid-19 At Labuang Baji Makassar Hospital. International Journal of Health and Pharmaceutical (IJHP), 1(1), 11–16. https://doi.org/10.51601/ijhp.v1i1.3